{
  "company": "Sanofi",
  "ticker": "SNY",
  "sector": "Pharmaceuticals",
  "scannedDate": "2026-02-07",
  "searchesCompleted": 0,
  "urlsFetched": 2,
  "fetchFailures": [],
  "structuralFindings": {
    "suggestedModel": 4,
    "suggestedModelName": "Hybrid/Hub-and-Spoke",
    "suggestedOrientation": "Structural",
    "confidence": "Medium",
    "rationale": "Based on existing specimen classification. New observations from earnings/research session.",
    "aiTeamStructure": null,
    "keyPeople": null,
    "investmentSignals": null,
    "observableMarkers": {}
  },
  "quotes": [],
  "sources": [
    {
      "name": "Hudson frames Sanofi as 'R&D-driven, AI-powered biopharma company'",
      "url": "https://www.sanofi.com/en/media-room/press-releases/2026/2026-01-29-06-30-00-3228191",
      "type": "Press",
      "date": "2026-01-29",
      "notes": "Hudson frames Sanofi as 'R&D-driven, AI-powered biopharma company'"
    },
    {
      "name": "ROAI (Return on AI Investment) framework introduced",
      "url": "https://www.statnews.com/2025/11/17/roai-return-investment-ai-sanofi-paul-hudson/",
      "type": "Press",
      "date": "2025-11-17",
      "notes": "ROAI (Return on AI Investment) framework introduced"
    }
  ],
  "summary": "Hudson frames Sanofi as 'R&D-driven, AI-powered biopharma company': CEO Paul Hudson described Sanofi's strategic identity as an 'R&D-driven, AI-powered biopharma company' during Q4 2025 results. This framing elevates AI from a tool to a core identity claim, consistent ROAI (Return on AI Investment) framework introduced: Hudson published a STAT article introducing ROAI as a measurement framework for AI value. The article notes 95% of AI pilot projects fail (citing MIT), positioning Sanofi as moving beyond pilots. Full Opella divestiture completed, reinvestment in AI and M&A: The completion of the Opella consumer health transaction enabled reinvestment into business development and M&A. Combined with a 5 billion euro share buyback, this represents strategic portfolio simpl",
  "openQuestions": [],
  "splitFrom": "pharma-earnings-q4-2025.json"
}
